
Blood Testing Market Share, Size, Trends, Industry Analysis Report, By Test (CBC test, Blood glucose test, Lipid panel testing, Covid-19, BUN testing (Blood Urea Nitrogen), A1C, Cortisol, Creatinine, Others), By Product, By Method, By End-Use, By Region,
Description
The blood testing market size is expected to reach USD 233.74 Billion by 2034, according to a new study by Polaris Market Research. The report “Blood Testing Market Share, Size, Trends, Industry Analysis Report, By Test (CBC test, Blood glucose test, Lipid panel testing, Covid-19, BUN testing (Blood Urea Nitrogen), A1C, Cortisol, Creatinine, Others), By Product, By Method, By End-Use, By Region, Segments & Forecast, 2025 – 2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The increasing prevalence of chronic and infectious diseases, technological advancements in blood testing devices, and the need for point-of-care (POC) testing centers are the prime factors expected to drive the market in the forecast period.
A blood test is a medical procedure in which a healthcare professional draws blood samples from a patient's vein using a needle, syringe, or another device. Blood tests are used for various purposes, including diagnosing diseases and medical conditions, monitoring the effectiveness of treatments, and evaluating overall health.
The increasing prevalence of chronic and infectious diseases drives demand for blood testing services and products, creating growth opportunities for companies in the blood testing market. Companies that can provide innovative, accurate, and cost-effective solutions to meet the growing demand for blood testing are likely to succeed in this dynamic market.
For instance, as per International Diabetes Federation, India has the highest number of people with diabetes in the world with about 77 million people living with diabetes and was projected to reach a value of 134 million by 2045. The increasing chronic diseases in India and other countries have necessitated blood testing to detect the disease.
Blood glucose test is expected to account for the fastest growth rate in the forecast period. The growth of the blood glucose test segment is driven by the rising prevalence of diabetes, technological advancements, increasing awareness of the importance of monitoring blood glucose, and various government initiatives.
Reagents & Kits are anticipated to dominate the market in the forecast period. A combination of increasing demand for blood transfusions, technological advancements, rising awareness of blood safety, and government initiatives is driving the growth of the reagents and kits segment.
The automated segment is the fastest-growing segment in the market. A combination of increased efficiency, technological advancements, cost savings, and growing demand for blood testing is driving the growth of the automated blood testing method.
North America region is projected to account for the fastest growth rate in the forecast period. The growth of the blood testing market in North America is driven by a combination of factors, including the growing prevalence of chronic diseases, technological advancements, strong healthcare infrastructure, increasing focus on preventive healthcare, and favorable reimbursement policies.
Polaris Market Research has segmented the blood testing market by test, product, method, end-use, and region:
Blood Testing Market, Test Outlook (Revenue - USD Billion, 2020 - 2034)
CBC test
Blood glucose test
Lipid panel testing
Covid-19
BUN testing (Blood Urea Nitrogen)
A1C
Cortisol
Creatinine
Others
Blood Testing Market, Product Outlook (Revenue - USD Billion, 2020 - 2034)
Reagents & Kits
Instruments
Software
Blood Testing Market, Method Outlook (Revenue - USD Billion, 2020 - 2034)
Automated
Manual
Blood Testing Market, End-Use Outlook (Revenue - USD Billion, 2020 - 2034)
Hospitals
Pathology labs
Blood banks
Diagnostic centres
Others
Blood Testing Market, Regional Outlook (Revenue - USD Billion, 2020 - 2034)
North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Latin America
Argentina
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
The increasing prevalence of chronic and infectious diseases, technological advancements in blood testing devices, and the need for point-of-care (POC) testing centers are the prime factors expected to drive the market in the forecast period.
A blood test is a medical procedure in which a healthcare professional draws blood samples from a patient's vein using a needle, syringe, or another device. Blood tests are used for various purposes, including diagnosing diseases and medical conditions, monitoring the effectiveness of treatments, and evaluating overall health.
The increasing prevalence of chronic and infectious diseases drives demand for blood testing services and products, creating growth opportunities for companies in the blood testing market. Companies that can provide innovative, accurate, and cost-effective solutions to meet the growing demand for blood testing are likely to succeed in this dynamic market.
For instance, as per International Diabetes Federation, India has the highest number of people with diabetes in the world with about 77 million people living with diabetes and was projected to reach a value of 134 million by 2045. The increasing chronic diseases in India and other countries have necessitated blood testing to detect the disease.
Blood glucose test is expected to account for the fastest growth rate in the forecast period. The growth of the blood glucose test segment is driven by the rising prevalence of diabetes, technological advancements, increasing awareness of the importance of monitoring blood glucose, and various government initiatives.
Reagents & Kits are anticipated to dominate the market in the forecast period. A combination of increasing demand for blood transfusions, technological advancements, rising awareness of blood safety, and government initiatives is driving the growth of the reagents and kits segment.
The automated segment is the fastest-growing segment in the market. A combination of increased efficiency, technological advancements, cost savings, and growing demand for blood testing is driving the growth of the automated blood testing method.
North America region is projected to account for the fastest growth rate in the forecast period. The growth of the blood testing market in North America is driven by a combination of factors, including the growing prevalence of chronic diseases, technological advancements, strong healthcare infrastructure, increasing focus on preventive healthcare, and favorable reimbursement policies.
Polaris Market Research has segmented the blood testing market by test, product, method, end-use, and region:
Blood Testing Market, Test Outlook (Revenue - USD Billion, 2020 - 2034)
CBC test
Blood glucose test
Lipid panel testing
Covid-19
BUN testing (Blood Urea Nitrogen)
A1C
Cortisol
Creatinine
Others
Blood Testing Market, Product Outlook (Revenue - USD Billion, 2020 - 2034)
Reagents & Kits
Instruments
Software
Blood Testing Market, Method Outlook (Revenue - USD Billion, 2020 - 2034)
Automated
Manual
Blood Testing Market, End-Use Outlook (Revenue - USD Billion, 2020 - 2034)
Hospitals
Pathology labs
Blood banks
Diagnostic centres
Others
Blood Testing Market, Regional Outlook (Revenue - USD Billion, 2020 - 2034)
North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Latin America
Argentina
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Table of Contents
118 Pages
- 1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
- 2. Executive Summary
- 2.1. Market Highlights
- 3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
- 4. U.S. Patient Temperature Management Market Insights
- 4.1. Patient Temperature Management Market – Market Snapshot
- 4.2. Patient Temperature Management Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rising Prevalence of Chronic Diseases and Critical Illnesses Increasing ICU Admissions and Demand for Temperature Control Systems
- 4.2.1.2. Increasing Healthcare Spending Coupled with Well-Established Healthcare Infrastructure
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High Equipment and Maintenance Costs
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Patient Temperature Management Market Trends
- 4.6. Value Chain Analysis
- 5. U.S. Patient Temperature Management Market, by Product
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. U.S. Patient Temperature Management Market, by Product, 2020-2034 (USD Billion)
- 5.3. Patient Warning Systems
- 5.3.1. U.S. Patient Temperature Management Market, by Patient Warning Systems, by Region, 2020-2034 (USD Billion)
- 5.3.1.1. U.S. Patient Temperature Management Market, by Conventional Warning Systems, by Region, 2020-2034 (USD Billion)
- 5.3.1.2. U.S. Patient Temperature Management Market, by Surface Warning Systems, by Region, 2020-2034 (USD Billion)
- 5.3.1.3. U.S. Patient Temperature Management Market, by Intravascular Warning Systems, by Region, 2020-2034 (USD Billion)
- 5.4. Patient Cooling Systems
- 5.4.1. U.S. Patient Temperature Management Market, by Patient Cooling Systems, by Region, 2020-2034 (USD Billion)
- 5.4.1.1. U.S. Patient Temperature Management Market, by Conventional Warning Systems, by Region, 2020-2034 (USD Billion)
- 5.4.1.2. U.S. Patient Temperature Management Market, by Surface Warning Systems, by Region, 2020-2034 (USD Billion)
- 5.4.1.3. U.S. Patient Temperature Management Market, by Intravascular Warning Systems, by Region, 2020-2034 (USD Billion)
- 6. U.S. Patient Temperature Management Market, by Application
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. U.S. Patient Temperature Management Market, by Application, 2020-2034 (USD Billion)
- 6.3. General Surgery
- 6.3.1. U.S. Patient Temperature Management Market, by General Surgery, by Region, 2020-2034 (USD Billion)
- 6.4. Cardiology
- 6.4.1. U.S. Patient Temperature Management Market, by Cardiology, by Region, 2020-2034 (USD Billion)
- 6.5. Pediatrics
- 6.5.1. U.S. Patient Temperature Management Market, by Pediatrics, by Region, 2020-2034 (USD Billion)
- 6.6. Neurology
- 6.6.1. U.S. Patient Temperature Management Market, by Neurology, by Region, 2020-2034 (USD Billion)
- 6.7. Orthopedic Surgery
- 6.7.1. U.S. Patient Temperature Management Market, by Orthopedic Surgery, by Region, 2020-2034 (USD Billion)
- 6.8. Thoracic Surgery
- 6.8.1. U.S. Patient Temperature Management Market, by Thoracic Surgery, by Region, 2020-2034 (USD Billion)
- 6.9. Other
- 6.9.1. U.S. Patient Temperature Management Market, by Other, by Region, 2020-2034 (USD Billion)
- 7. U.S. Patient Temperature Management Market, by End Use
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. U.S. Patient Temperature Management Market, by End Use, 2020-2034 (USD Billion)
- 7.3. Hospitals
- 7.3.1. U.S. Patient Temperature Management Market, by Hospitals, by Region, 2020-2034 (USD Billion)
- 7.4. Ambulatory surgical centers
- 7.4.1. U.S. Patient Temperature Management Market, by Ambulatory surgical centers, by Region, 2020-2034 (USD Billion)
- 7.5. Neonatal care units
- 7.5.1. U.S. Patient Temperature Management Market, by Neonatal care units, by Region, 2020-2034 (USD Billion)
- 7.6. Specialized clinics
- 7.6.1. U.S. Patient Temperature Management Market, by Specialized clinics, by Region, 2020-2034 (USD Billion)
- 7.7. Other end-users
- 7.7.1. U.S. Patient Temperature Management Market, by Other end-users, by Region, 2020-2034 (USD Billion)
- 8. U.S. Patient Temperature Management Market, by Geography
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Patient Temperature Management Market Assessment, By Country, 2020-2034 (USD Billion)
- 8.3. Patient Temperature Management Market – U.S.
- 8.3.1. U.S.: Patient Temperature Management Market, by Product, 2020-2034 (USD Billion)
- 8.3.2. U.S.: Patient Temperature Management Market, by Application, 2020-2034 (USD Billion)
- 8.3.3. U.S.: Patient Temperature Management Market, by End Use, 2020-2034 (USD Billion)
- 9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
- 10. Company Profiles
- 10.1. 3M Company
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. Atom Medical Corporation
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. Augustine Surgical, Inc.
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Bard Medical Division
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. Cincinnati Sub-Zero Products, LLC
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. Drägerwerk AG & Co. KGaA
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. Geratherm Medical AG
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. ICU Medical, Inc.
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. Inditherm Plc
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. Medtronic plc
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
- 10.11. Smiths Medical
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
- 10.12. The Surgical Company Group
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.